Burleson & Company, LLC Cortexyme, Inc. Call Options Transaction History

Burleson & Company, LLC

$384 Million
Q4 2022

Call Options

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q4 2022 Jan 30, 2023	SELL	N/A	-79,500 Reduced 48.56%	84,200 $108,000
Q3 2022 Oct 17, 2022	BUY	$1.29 - $2.52 $19,350 - $37,800	15,000 Added 10.09%	163,700 $23,000
Q2 2022 Jul 13, 2022	SELL	$2.22 - $6.7 $207,570 - $626,450	-93,500 Reduced 38.6%	148,700 $58,000
Q1 2022 Apr 25, 2022	BUY	$4.18 - $13.39 $658,768 - $2.11 Million	157,600 Added 186.29%	242,200 $240,000
Q4 2021 Jan 25, 2022	SELL	$11.35 - $97.17 $1.76 Million - $15.1 Million	-155,000 Reduced 64.69%	84,600 $130,000
Q3 2021 Nov 02, 2021	BUY	$52.0 - $120.21 $10.1 Million - $23.4 Million	195,000 Added 437.22%	239,600 $5.36 Million
Q1 2021 May 12, 2021	BUY	$28.6 - $49.21 $1.08 Million - $1.87 Million	37,900 Added 565.67%	44,600 $696,000
Q3 2020 Nov 10, 2020	BUY	$39.85 - $57.3 $266,995 - $383,910	6,700 New	6,700 $93,000

Others Institutions Holding CRTX

# of Institutions

49

Shares Held

6.26M

Call Options Held

101K

Put Options Held

400

Tang Capital Management LLC San Diego, CA

1.5M
Shares

$1.94 Million
0.24% of portfolio
Vanguard Group Inc Valley Forge, PA

1.21M
Shares

$1.57 Million
0.0% of portfolio
Epiq Capital Group, LLC San Francisco, CA

852K
Shares

$1.1 Million
0.41% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

484K
Shares

$624,233
0.0% of portfolio
Black Rock Inc. New York, NY

355K
Shares

$457,676
0.0% of portfolio

About Cortexyme, Inc.

Ticker CRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,150,800
Market Cap $70.5M

More about CRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.